Clinical Trial Update: Evaluate the Efficacy and Safety of DWP16001 in Type 2 Diabetic Nephropathy with Moderate Renal Impairment Patients [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating the efficacy and safety of DWP16001 in patients with diabetic nephropathy; the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Nephropathy

Drugs mentioned

• DWP16001

Snippet

Sponsor: Daewoong Pharmaceutical Co. LTD. | Conditions: Type 2 Diabetic Nephropathy | Phase 3 | Status: NOT_YET_RECRUITING